{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"3.680","floor":"3.070"},"ipodate":{"start":"2019-06-28 00:00:00","end":"2019-07-05 00:00:00"},"minimumcapital":"3717.08","subscribed":"2.21","marketcap":"40.94億","H_marketcap":"--","pe":"34.93","codesrate":"50.00","link":"https://staticpdf.iqdii.com/stockdata/notice/01931/2019/ltn201906281711_c.pdf","ipopricing":"3.070","resultdate":"2019-07-11 00:00:00","enddate":"2019-07-05 00:00:00","listeddate":"2019-07-12 00:00:00","issuenumber":"33340.00萬","issuenumberhK":"3334.00萬","issuenumberother":"30006.00萬","grayprice":"3.05","sponsors":"中銀國際亞洲有限公司","raisemoney":"93170.00萬","use":"1、約49.6%或461.7百萬港元將用于結清收購威士達60%股權的現金代價之未償還結余；\n2、約32.9%或306.8百萬港元將用于根據股東協議向本公司及威士達現有股東支付部分特別股息；\n3、約6.8%或63.7百萬港元將主要用于擴大分銷業務項下的客戶群；\n4、約3.5%或32.5百萬港元將用于繼續研發我們的自有品牌產品；\n5、約2.6%或24.0百萬港元將用于擴展我們的分銷業務及改善我們的分銷價值鏈；\n6、約4.6%或43.0百萬港元將用于營運資金及一般公司用途。","shares":1000,"leadagent":"中銀國際亞洲有限公司,尚乘環球市場有限公司,興證國際融資有限公司,海通國際證券有限公司","bookrunners":"中銀國際亞洲有限公司,尚乘環球市場有限公司,興證國際融資有限公司,海通國際證券有限公司","coordinator":"中銀國際亞洲有限公司","firstDayOpen":"2.81","IsEiio":0,"Interestdays":6,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"中銀國際亞洲有限公司","code":"E01931","name":"華檢醫療","fullname":"華檢醫療控股有限公司"},"institutioninfo":{"principaloffice":"中國上海市浦東新區張江高科技園區畢升路299弄第一上海中心6號樓602室","registrars":"卓佳證券登記有限公司","registrarstel":"(852) 2980 1333","chairman":"何鞠誠","secretary":"林惠茵","telephone":"4008209809","substantialshareholders":"華佗(33.27%),KS&KL(13.16%),King Sun(13.16%),Lucan Investment(8.45%),NHPE(6.95%)","principalactivities":"公司為中國IVD產品分銷商。","website":"http://www.ivdholding.com"},"managerinfo":[{"managername":"何鞠誠","post":"主席、行政總裁兼執行董事","rankno":1},{"managername":"梁景新","post":"運營總監兼執行董事","rankno":2},{"managername":"林賢雅","post":"總經理兼執行董事","rankno":3}],"investorinfo":[],"TotalShareholdingPercentage":0},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":516}